Perphenazine-benztropine mesylate treatment of newly admitted psychiatric patients.
D000293:Adolescent; D000328:Adult; D002986:Clinical Trials as Topic; D004357:Drug Synergism; D005116:Extrapyramidal Tracts / Q000187:drug effects; D005260:Female; D006778:Hospitals, Psychiatric; D006801:Humans; D008396:Maryland; D008875:Middle Aged; D009069:Movement Disorders / Q000139:chemically induced; D010276:Parasympatholytics / Q000627:therapeutic use*; D010546:Perphenazine / Q000627:therapeutic use*; D010555:Personality Inventory; D010919:Placebos; D011600:Psychopharmacology; D011618:Psychotic Disorders / Q000188:drug therapy*
D010276:Parasympatholytics; D010919:Placebos; D010546:Perphenazine